- Home
- BPTH vs FOXO Comparison
BPTH vs FOXO Comparison
Compare BPTH & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPTH
- FOXO
- Stock Information
- Founded
- BPTH 2007
- FOXO 2019
- Country
- BPTH United States
- FOXO United States
- Employees
- BPTH N/A
- FOXO N/A
- Industry
- BPTH Biotechnology: Pharmaceutical Preparations
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- BPTH Health Care
- FOXO Technology
- Exchange
- BPTH Nasdaq
- FOXO Nasdaq
- Market Cap
- BPTH 2.2M
- FOXO 2.6M
- IPO Year
- BPTH N/A
- FOXO N/A
- Fundamental
- Price
- BPTH $0.87
- FOXO $0.18
- Analyst Decision
- BPTH Strong Buy
- FOXO
- Analyst Count
- BPTH 2
- FOXO 0
- Target Price
- BPTH $30.00
- FOXO N/A
- AVG Volume (30 Days)
- BPTH 81.3K
- FOXO 156.3K
- Earning Date
- BPTH 11-13-2024
- FOXO 08-19-2024
- Dividend Yield
- BPTH N/A
- FOXO N/A
- EPS Growth
- BPTH N/A
- FOXO N/A
- EPS
- BPTH N/A
- FOXO N/A
- Revenue
- BPTH N/A
- FOXO $155,000.00
- Revenue This Year
- BPTH N/A
- FOXO N/A
- Revenue Next Year
- BPTH N/A
- FOXO N/A
- P/E Ratio
- BPTH N/A
- FOXO N/A
- Revenue Growth
- BPTH N/A
- FOXO N/A
- 52 Week Low
- BPTH $0.86
- FOXO $0.06
- 52 Week High
- BPTH $21.60
- FOXO $1.02
- Technical
- Relative Strength Index (RSI)
- BPTH 34.38
- FOXO 46.81
- Support Level
- BPTH $0.86
- FOXO $0.17
- Resistance Level
- BPTH $0.92
- FOXO $0.20
- Average True Range (ATR)
- BPTH 0.06
- FOXO 0.01
- MACD
- BPTH 0.01
- FOXO -0.00
- Stochastic Oscillator
- BPTH 5.79
- FOXO 23.24
About BPTH Bio-Path Holdings Inc.
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.